Clinical trial
Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
NCT02730793 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2017
- Completion date
- September 19, 2019
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.